Ainkaran Santhirasekaram

Papers

Total Citations

H-Index

About

Ainkaran Santhirasekaram is a researcher whose work sits at the intersection of urological oncology and surgical outcomes, with a particular focus on improving prognostication for high-risk prostate cancer. His most cited study, published in 2021, critically examined whether tumour volume serves as an independent predictor of outcomes following radical prostatectomy. This work challenges the conventional staging paradigm—which relies on PSA, ISUP grade group, and multiparametric MRI—by arguing that tumour volume, a metric used in other solid organ cancers, is underutilised in prostate cancer. By analysing the predictive value of crude estimates like maximum cancer core length, Santhirasekaram’s research contributes to a more refined risk stratification for patients with aggressive disease. While his citation count of 7 reflects a growing interest in this niche, his work has direct implications for surgical planning and postoperative management. His findings encourage a shift toward integrating volumetric data into clinical decision-making, potentially improving the accuracy of prognosis for high-risk patients. For students and researchers in urological oncology, Santhirasekaram’s work underscores the importance of re-evaluating established staging tools to enhance personalised treatment strategies.